tiprankstipranks
Trending News
More News >
Fresenius Medical Care Corp. (FMS)
NYSE:FMS
US Market

Fresenius Medical Care (FMS) Ratios

Compare
361 Followers

Fresenius Medical Care Ratios

FMS's free cash flow for Q4 2025 was €0.27. For the 2025 fiscal year, FMS's free cash flow was decreased by € and operating cash flow was €0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.26 1.26 1.40 1.42 1.27
Quick Ratio
0.92 0.92 1.03 1.07 0.91
Cash Ratio
0.26 0.26 0.21 0.23 0.20
Solvency Ratio
0.15 0.14 0.13 0.12 0.12
Operating Cash Flow Ratio
0.42 0.41 0.42 0.43 0.34
Short-Term Operating Cash Flow Coverage
1.65 1.60 4.13 2.78 1.61
Net Current Asset Value
€ -8.82B€ -8.82B€ -9.88B€ -10.40B€ -12.10B
Leverage Ratios
Debt-to-Assets Ratio
0.35 0.35 0.33 0.36 0.37
Debt-to-Equity Ratio
0.76 0.76 0.75 0.89 0.94
Debt-to-Capital Ratio
0.43 0.43 0.43 0.47 0.49
Long-Term Debt-to-Capital Ratio
0.28 0.28 0.30 0.34 0.34
Financial Leverage Ratio
2.17 2.17 2.30 2.49 2.56
Debt Service Coverage Ratio
1.58 1.63 2.94 2.12 1.82
Interest Coverage Ratio
6.86 0.00 3.42 3.22 4.20
Debt to Market Cap
0.64 0.62 0.53 0.70 0.48
Interest Debt Per Share
19.34 18.54 19.41 21.30 11.57
Net Debt to EBITDA
2.79 3.11 3.06 3.33 3.49
Profitability Margins
Gross Profit Margin
25.62%25.62%24.60%25.32%25.23%
EBIT Margin
9.06%7.70%7.57%7.49%8.14%
EBITDA Margin
16.79%15.06%16.58%16.50%17.62%
Operating Profit Margin
9.31%9.31%7.20%7.04%7.79%
Pretax Profit Margin
7.71%7.70%5.47%5.31%6.29%
Net Profit Margin
4.98%4.98%2.78%2.57%3.47%
Continuous Operations Profit Margin
6.07%6.07%3.83%3.77%4.61%
Net Income Per EBT
64.67%64.68%50.89%48.30%55.23%
EBT Per EBIT
82.79%82.76%75.91%75.43%80.65%
Return on Assets (ROA)
3.16%3.15%1.60%1.47%1.88%
Return on Equity (ROE)
7.13%6.85%3.69%3.66%4.81%
Return on Capital Employed (ROCE)
7.38%7.38%4.99%4.92%5.16%
Return on Invested Capital (ROIC)
5.34%5.34%3.35%3.30%3.54%
Return on Tangible Assets
6.05%6.05%3.16%2.78%3.65%
Earnings Yield
8.62%8.28%4.19%4.42%3.76%
Efficiency Ratios
Receivables Turnover
6.25 6.25 5.67 5.35 5.21
Payables Turnover
19.78 19.78 14.81 16.41 15.24
Inventory Turnover
6.82 6.82 7.05 6.67 6.32
Fixed Asset Turnover
6.51 6.51 2.66 2.61 2.33
Asset Turnover
0.63 0.63 0.58 0.57 0.54
Working Capital Turnover Ratio
10.56 10.03 7.97 8.99 15.86
Cash Conversion Cycle
93.51 93.51 91.48 100.77 103.83
Days of Sales Outstanding
58.43 58.43 64.35 68.26 69.99
Days of Inventory Outstanding
53.53 53.53 51.77 54.75 57.78
Days of Payables Outstanding
18.45 18.45 24.64 22.24 23.95
Operating Cycle
111.96 111.96 116.12 123.01 127.78
Cash Flow Ratios
Operating Cash Flow Per Share
4.64 4.42 4.06 4.48 1.85
Free Cash Flow Per Share
3.06 2.91 2.87 3.31 1.23
CapEx Per Share
1.58 1.51 1.19 1.17 0.62
Free Cash Flow to Operating Cash Flow
0.66 0.66 0.71 0.74 0.67
Dividend Paid and CapEx Coverage Ratio
2.00 2.00 2.28 2.59 1.94
Capital Expenditure Coverage Ratio
2.94 2.93 3.41 3.84 2.99
Operating Cash Flow Coverage Ratio
0.25 0.24 0.22 0.22 0.16
Operating Cash Flow to Sales Ratio
0.14 0.13 0.12 0.14 0.11
Free Cash Flow Yield
15.31%14.36%13.12%17.23%8.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.59 12.07 23.89 22.62 26.58
Price-to-Sales (P/S) Ratio
0.58 0.60 0.66 0.58 0.92
Price-to-Book (P/B) Ratio
0.79 0.83 0.88 0.83 1.28
Price-to-Free Cash Flow (P/FCF) Ratio
6.52 6.96 7.62 5.80 12.40
Price-to-Operating Cash Flow Ratio
4.27 4.58 5.39 4.29 8.26
Price-to-Earnings Growth (PEG) Ratio
0.27 0.14 3.12 0.47 -0.87
Price-to-Fair Value
0.79 0.83 0.88 0.83 1.28
Enterprise Value Multiple
6.26 7.10 7.07 6.84 8.73
Enterprise Value
20.64B 21.00B 22.68B 21.96B 29.84B
EV to EBITDA
6.26 7.10 7.07 6.84 8.73
EV to Sales
1.05 1.07 1.17 1.13 1.54
EV to Free Cash Flow
11.79 12.38 13.44 11.30 20.67
EV to Operating Cash Flow
7.78 8.16 9.50 8.35 13.77
Tangible Book Value Per Share
-0.95 -0.93 -1.31 -2.02 -1.59
Shareholders’ Equity Per Share
24.98 24.53 24.79 23.20 11.93
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.30 0.29 0.27
Revenue Per Share
34.33 33.70 32.89 33.14 16.54
Net Income Per Share
1.71 1.68 0.91 0.85 0.57
Tax Burden
0.65 0.65 0.51 0.48 0.55
Interest Burden
0.85 1.00 0.72 0.71 0.77
Research & Development to Revenue
0.01 <0.01 <0.01 0.01 0.01
SG&A to Revenue
0.06 0.00 0.12 0.12 0.12
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 0.00
Income Quality
2.49 2.74 3.22 3.59 2.42
Currency in EUR